{"id":36564,"date":"2026-08-29T18:19:23","date_gmt":"2026-08-29T12:49:23","guid":{"rendered":"https:\/\/niir.org\/blog\/?p=36564"},"modified":"2026-08-29T17:54:12","modified_gmt":"2026-08-29T12:24:12","slug":"ghana-pharmaceutical-industrial-park","status":"publish","type":"post","link":"https:\/\/www.niir.org\/blog\/ghana-pharmaceutical-industrial-park\/","title":{"rendered":"Ghana Is Building a 2,000-Acre Pharma Park \u2014 And It Could Be Africa\u2019s Biggest Manufacturing Bet of 2026"},"content":{"rendered":"

A continent that relies on foreign drugs is now setting up the drug factories. The government under the 24-Hour Economy programme is planning to develop a pharmaceutical industrial park occupying an estimated 2,000 acres in the Shai-Osudoku District of Ghana. It will feature an integrated environment for the manufacturing of drugs, medical devices, herbal medicine, research and development, and allied health products.<\/p>\n

According to Citi Newsroom<\/a>, pre-feasibility studies are now complete, an anchor investor is already secured and a long list of tenants from India, China, and the United States are in active discussions. Today, about 70 per cent of Ghana’s pharmaceuticals are imported, which is a structural weakness the park is aimed at correcting.<\/p>\n

The news is not a red flag or a rumour for the entrepreneurs, MSME manufacturers, exporters and investors who keep a close eye on the African pharma market. It’s like a starting gun. The ecosystem is in the design phase. A single building hasn’t been built yet, but supply chains, tenant roles and technology partnerships are being formed. The firms involved will shape the future of West African drug production over the next 20 years.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n